fadi khasawneh_cv - faculty profileshb2504.utep.edu/vitas/fkhasawneh.doc · web viewkhasawneh...

FADI T. KHASAWNEH, PH.D. Associate Professor (with tenure) and Chair, Pharmaceutical Sciences

EDUCATION

Ph.D., Pharmacology, University of Illinois at Chicago, Chicago, IL, USA May 2007

B.S., Pharmacy (B.Pharm.), Jordan University of Science & Technology, JORDAN February 1999

PROFESSIONAL AND ACADEMIC EXPERIENCE

Associate Professor School of Pharmacy, University of Texas at El Paso, El Paso, TX(October 2016 - present)

Associate Professor College of Pharmacy, Western University of Health Sciences, Pomona, CA

(July 2013 - October 2016)

Assistant Professor College of Pharmacy, Western University of Health Sciences, Pomona, CA

(Feb 2008 - June 2013)

Associate Member Graduate College of Biomedical Sciences, Western University of Health

(Nov 2010 - present) Sciences, Pomona, CA

Postdoctoral Research Department of Pharmacology, College of Medicine, The University of Associate Illinois at Chicago, Chicago, IL(May 2007 - Feb 2008)

Research Assistant Department of Pharmacology, College of Medicine, The University of (Aug 2004 - May 2007) Illinois at Chicago, Chicago, IL

Teaching Assistant Department of Pharmacology, College of Medicine, The University of (Aug 2001 - Jul 2005) Illinois at Chicago, Chicago, IL

In addition to other teaching-related activities, conducted medical pharmacology review sessions for Urban Health Program medical students for three years

Teaching Assistant College of Pharmacy, Jordan University of Science and Technology(Oct 2000 - Jun 2001) Irbid, Jordan

Taught the following instructional laboratories: Pharmacognosy, Analytical Chemistry I, Analytical Chemistry II, and Organic Chemistry.

Research Assistant College of Pharmacy, Jordan University of Science and Technology(Jan 2000 - Jan 2001) Irbid, Jordan

Fadi T. Khasawneh – of 17

Pharmaceutical SciencesSchool of Pharmacy University of Texas at El Paso1101 N. Campbell St, Room 711El Paso, Texas 79902

Phone (O): (915) 747-8187 Phone (H): (312) 753-8637 Fax: (915) 747-8521

E-mail: [email protected] URL:

http://www.utep.edu/pharmacy/

http://www.utep.edu/pharmacy/

mailto:[email protected]

Conducted comprehensive quality control analysis for pharmaceutical products.

Applications included: Tablet Tests included disintegration, dissolution, hardness, uniformity, friability, and potency assays.

Hospital Pharmaceuticals Hikma Pharmaceutical CompanySpecialist Amman, JORDAN(Apr 1999 - May 2000) Intern Department of Pharmacy & Providence at Al-Hussein Medical (Jun 1998 - Sep 1998) Center, Department of Royal Medical Services

PUBLICATIONS

Journal Publications (Peer-Reviewed)1. Khasawneh F.T., Huang J., Turek J., and Le Breton, G.C., “Differential Mapping of the Amino

Acids Mediating Agonist and Antagonist Coordination with the Human Thromboxane A2

Receptor Protein”, J Biol Chem. 2006 Sep;281(37):26951-652. Khasawneh F.T., Huang J., Mir F., Srinivasan S., Tiruppathi C., and Le Breton, G.C.,

“Characterization of Isoprostane Signaling: Evidence for a Unique Coordination Profile of 8-iso-PGF2α with the Thromboxane A2 Receptor, and Activation of a Separate cAMP-Dependent Inhibitory Pathway in Human Platelets”, Biochem Pharmacol. 2008 Jun;75(12):2301-15.

3. Srinivasan S., Mir F., Huang J., Khasawneh F.T., Lam S.C., and Le Breton, G.C., “The P2Y12 Antagonists, 2-Methylthioadenosine 5’-Monophosphate Triethylammonium Salt and Cangrelor (ARC69931MX), Can Inhibit Human Platelet Aggregation through a Gi-independent Increase in cAMP Levels” , J Biol Chem. 2009 Jun;284(24):16108-17.

4. Ting H.J., Murray W.J., and Khasawneh F.T., “Repurposing An Old Drug for A New Use: Glybenclamide Exerts Antiplatelet Activity By Interacting with the Thromboxane A2

Receptor”, Acta Pharmacol Sin. 2010 Feb;31(2):150-95. Ting H.J., and Khasawneh F.T., “Platelet Function and Isoprostane Biology. Should

Isoprostanes Be the Newest Member of the Orphan-Ligand Family?”, J Biomed Sci. 2010 Apr;17(1):24.

6. Ting H.J., and Khasawneh F.T., “Glybenclamide: an Antidiabetic with in vivo Antithrombotic Activity”, Eur J Pharmacol. 2010 Dec;649(1-3):249-54.

7. Gussin H.A.*, Khasawneh F.T.*, Xie A., Feng F., Memic A., Qian H., Le Breton, G.C., and Pepperberg D.R., “Subunit-Specific Polyclonal Antibody Targeting Human 1 GABAC

Receptor”, Exp Eye Res. 2011 Jul;93(1):59-64. (*Authors contributed equally to this work)8. Ting H.J., Murad J.P., Espinosa E.V.P., and Khasawneh F.T., “Thromboxane A2 Receptor:

Biology and Function of a Peculiar Receptor that Remains Resistant for Therapeutic Targeting”, J Cardiovasc Pharmacol Ther. 2012 Sep;17(3):248-59.

9. Zargarzadeh A., Jacob S., Klotz S.R., and Khasawneh F.T., “Clinical Pharmacists and Basic Scientists: Do Patients and Physicians Need this Collaboration?”, Int J Clin Pharm. 2011 Dec;33(6):886-94.

10. Murad J.P., Ting H.J., Espinosa E.V.P., and Khasawneh F.T., “Characterization of the in vivo Antiplatelet Activity of the Antihypertensive Agent Losartan”, J Cardiovasc Pharmacol Ther. 2012 Sep;17(3):308-14.

11. Espinosa E.V.P., Murad J.P., and Khasawneh F.T., “Aspirin: Pharmacology and Clinical Applications”, Thrombosis. 2012 Nov;2012:173124.

12. Guerra D., Morris D., Sipin A., Kung S., Franklin M., Gray D., Tanzil M., Guilford T., Khasawneh F.T., and Venketaraman V., “Glutathione and Adaptive Immune Responses Against Mycobacterium Tuberculosis Infection in Healthy and HIV Infected Individuals”, PLoS One. 2011 Dec;6(12):e28378.

13. Murad J.P., Ting H.J., Espinosa E.V.P., and Khasawneh F.T., “The C-terminal Segment of the Second Extracellular Loop of the Thromboxane A2 Receptor Plays an Important Role in Platelet Aggregation” ,Biochem Pharmacol. 2012 Jan;83(1):88-96.

14. Espinosa E.V.P., Murad J.P., Ting H.J., and Khasawneh F.T., “Mouse Transient Potential Channel 6: Role in Hemostasis and Thrombogenesis”, Biochem Biophys Res Commun. 2012 Jan;417(2):853-6.


15. Murad J.P., Espinosa E.V.P., Ting H.J., McClure D, and Khasawneh F.T., “A Novel Antibody Targeting the Ligand Binding Domain of the Thromboxane A2 Receptor Exhibits Antithrombotic Properties in vivo”, Biochem Biophys Res Commun. 2012 May;421(3):456-61.

16. Murad J.P., Lin O.A., Espinosa E.V.P., and Khasawneh F.T., “Current and Experimental Antibody-Based Therapeutics: Insights, Breakthroughs, Setbacks and Future Directions”, Curr Mol Med. 2013 Jan;13(1):165-78.

17. Lin O.A., Karim Z.A., Vemana H., Espinosa E.V.P., and Khasawneh F.T., “The Antidepressant 5-HT2A Receptor Antagonists Pizotifen and Cyproheptadine Inhibit Serotonin-Enhanced Platelet Function”, PLoS One. 2014 Jan;9(1):e87026.

18. Khasawneh F.T., and Shankar G.S., “Minimizing Cardiovascular Adverse Effects of Atypical Antipsychotic Drugs in Patients with Schizophrenia,” Cardiol Res Pract. 2014 Feb;2014:273060.

19. Karim Z.A., Vemana H., Alshbool F.Z., Lin O.A., Alshehri A.M., Javaherizadeh P., Espinosa E.V.P., and Khasawneh F.T., “Characterization of a Novel Function-Blocking Antibody Targeted Against The Platelet P2Y1 Receptor”, Arterioscler Thromb Vasc Biol. 2015 Mar;35(3):637-44.

20. Karim Z.A., Vemana H., and Khasawneh F.T., “MALT1-Ubiquitination Triggers Non-Genomic NF-B/IKK Signaling Upon Platelet Activation”, PLoS One. 2015 Mar;10(3):e0119363.

21. Karim Z.A., Alshbool F.Z., Vemana H., Adhami N., Dhall S., Espinosa E.V.P., Martins-Green M., and Khasawneh F.T., “Third Hand Smoke: Impact on Hemostasis and Thrombogenesis”, J Cardiovasc J Cardiovasc Pharmacol. 2015 Aug;66(2):177-82.

22. Vemana H., Karim Z.A., Conlon C., and Khasawneh F.T., “A Critical Role for the Transient Receptor Potential Channel Type 6 in Human Platelet Activation”, PLoS One. 2015 Apr;10(4):e0125764.

23. Alshbool F.Z., Karim Z.A., Vemana H., Conlon C., Lin O.A., Khasawneh F.T., “The Regulator Of G-Protein Signaling 18 Regulates Platelet Aggregation, Hemostasis And Thrombosis”, Biochem Biophys Res Commun. 2015 Jul;462(4):378-82.

24. Dhall S., Wijesinghe D.S., Karim Z.A., Castro A., Vemana HP, Khasawneh F.T., Chalfant, C.E, and Martins-Green, M., “Arachidonic acid-derived signaling lipids and functions in impaired healing”, Wound Repair Regen. 2015 Sep;23(5):644-56.

25. Karim Z.A., Alshbool F.Z., Vemana H.P., Conlon C., Druey K.M., and Khasawneh, F.T., “CXCL12 regulates platelet activation via the regulator of G-protein signaling 16”, Biochim Biophys Acta. Biochim Biophys Acta. 2016 Feb;1863(2):314-21

26. Dhall S., Karim Z.A., Khasawneh, F.T., and Martins-Green M. “Platelet Hyperactivity in TNFSF14/LIGHT Knockout Mouse Model of Impaired Healing”, Adv Wound Care. 2016 Oct 1;5(10):421-431.

27. Hensch N.R., Karim Z.A., Druey K.M., Tansey M.G., and Khasawneh F.T., “RGS10 Negatively Regulates Platelet Activation and Thrombogenesis”. PLoS One. 2016 Nov 9;11(11):e0165984.

Published Abstracts (Peer-Reviewed) 1. Khasawneh, F.T., Huang, J., Turek, J., and Le Breton, G.C., “Differential Mapping of the

Amino Acids Mediating Agonist and Antagonist Coordination with the Human Thromboxane A2

Receptor Protein,” Proceedings of the 2006 International Conference, “Frontiers of Pharmacology and Toxicology”, Chemico-Biological Interactions, Vol. 161(3), 218-218, July 2006.

2. Khasawneh, F.T., Huang, J., Turek, J., and Le Breton, G.C., “Differential Mapping of the Amino Acids Mediating Agonist and Antagonist Coordination with the Human Thromboxane A2 Receptor Protein.” Blood, Vol. 106(11), 996a-996a, November 2006.

3. Khasawneh, F.T., Huang, J., Tiruppathi, C., and Le Breton, G.C., “Molecular Characterization of the 8-iso-PGF2α Interaction with the Thromboxane A2 Receptor and its Signaling Mechanisms in Human Platelets,” The FASEB Journal, Vol. 21(5), 569.10, April 2007.

4. Srinivasan, S., Mir, F., Huang, J., Khasawneh, F.T., Huang, J., Lam, S., and Le Breton, G.C., “The adenosine-based P2Y12 antagonist, 2MeSAMP inhibits human platelet aggregation through a Gi-independent increase in platelet cAMP levels,” Arterioscler Thromb Vasc Biol, e-162 November 2008

5. Ting, H.J, Khasawneh, F.T., “Glybenclamide Exhibits Thromboxane Receptor-Dependent Antiplatelet Effects”, Late-Breaking Abstract, The FASEB Journal. 2009; 23: LB385.


6. Srinivasan, S., Mir, F., Huang, J., Khasawneh, F.T., Huang, J., Lam, S., and Le Breton, G.C., “ Cangrelor (ARC69931MX) produces global inhibition of human platelet function by increasing cAMP levels through a Gi-independent mechanism”, Late-Breaking Abstract, The FASEB Journal. 2009; 23: LB382.

7. Ting, H.J, Khasawneh, F.T., “The Thromboxane A2 Receptor-Specific Antiplatelet Effects of Glybenclamide”, American Journal of Pharmaceutical Education. 2009; 73 (4) Article 57

8. Ting, H.J, Shankar, G., and Khasawneh, F.T., “Investigation of the Anti‐Platelet Activity of a Novel Function‐Blocking Antibody Targeting the Human Thromboxane A2 Receptor Protein” platelet activation and biochemistry II, American Society of Hematology Meeting, December 7 2009.

9. Ting, H.J, and Khasawneh, F.T., “Drug Rediscovery: Glybenclamide Exhibits Thromboxane Receptor-Dependent Antithrombotic Activity” platelet activation and biochemistry II, American Society of Hematology Meeting, December 7 2009.

10. Murad, J.P., Ting, H.J, and Khasawneh, F.T., “The Transient Receptor-Potential Channel 6 Plays a Critical Role in Platelet Function”, 2010 American Society of Hematology Annual Meeting, Orlando, FL, December 6 2010.

11. Murad, J.P., Ting, H.J., and Khasawneh, F.T., “The Second Extracellular Loop of the Thromboxane Receptor Plays an Important Role in Platelet Activation”, Experimental Biology 2011 Meeting, Washington DC, April 13 2011.

12. Murad, J.P., Ting, H.J., and Khasawneh, F.T., “A Novel Mechanism for Calcium Entry Into Blood Platelets”, Late-Breaking Abstract, Experimental Biology 2011 Meeting; LB356, Washington DC, April 13 2011.

13. Khasawneh, F.T., Law, A.V., Jackevicius, C., Murray, W.J., Pham, D.Q., Chow, M.S.S, Scott, J.D., Prabhu, S., and Robinson, D.C., School Poster (submitted by Assessment Committee) “Assessment of basic and clinical science content integration in the didactic curriculum using curricular mapping”, July 9, 2011, AACP Annual Meeting.

14. Lin, O.A., Murad J.P., Espinosa E.V., and Khasawneh F.T., “Mapping of the G-Protein Coupling Domains of the Human Platelet Thromboxane A2 Receptor”, American Heart Association Scientific Sessions, Los Angeles, CA, November 5 2012

15. Espinosa E.V., Lin, O.A., Murad J.P., and Khasawneh F.T., “The Transient Receptor-Potential Channel 6 Regulates Thromboxane A2 Receptor-Operated Calcium Entry and Plays a Critical Role in Platelet Function”, Arteriosclerosis, Thrombosis, Vascular Biology Meeting, Lake Buena Vista, FL, May 1-3 2013

16. Vemana H.P., Karim Z.A., Lin, O.A., and Khasawneh F.T., ”Regulation of Platelet Activation by Transient Receptor Potential Channel 6”, Thrombosis & Hemostasis Summit of North American 2014, Chicago, IL, April 10-12 2014

17. Karim Z.A., Venkatesan N., Ting, H.J, Betageri G., and Khasawneh, F.T., “A Novel Parenteral Formulation For the Antiplatelet Agent Clopidogrel”, Late-Breaking Abstract, The FASEB Journal. 2016; LB532.

Editorials1. Khasawneh, F.T., and Karim, Z.A., “Lipid Raft and Platelet SNARE Machinery”, J Glycomics

Lipidomics 2014, 4: e119.

Abstracts and Posters1. Khasawneh, F.T., Huang, J., Turek, J., and Le Breton, G.C., “Identification of the Amino Acids

Involved in Ligand Binding to the Human Thromboxane A2 Receptor Protein,” Abstract, 10th

Biennial Midwest Platelet Conference, Milwaukee, Wisconsin, October 8-10, 2004.2. Khasawneh, F.T., Huang, J., Turek, J., and Le Breton, G.C., “Identification of the Amino Acids

Mediating Thromboxane A2 Receptor-Ligand Coordination,” Poster Presentation, The 36th

Annual Midwest Student Biomedical Research Forum, University of Nebraska Medical Center, Omaha, Nebraska, February 18-19, 2005.

3. Khasawneh, F.T., Huang, J., Turek, J., and Le Breton, G.C., “Identification of the Amino Acids Mediating Thromboxane A2 Receptor-Ligand Coordination,” Poster Presentation, 18th Annual Scientific Meeting of the Great Lakes Chapter, American Society for Pharmacology and Experimental Therapeutics, Midwestern University, Downers Grove, Illinois, June 17, 2005.

4. Khasawneh, F.T., Huang, J., Turek, J., and Le Breton, G.C., “Amino Acids Participating in the Human Thromboxane A2 Receptor Agonist and Antagonist Interaction Process,” Poster


Presentation, Department of Pharmacology Annual Retreat, Lake Geneva, Wisconsin, September 29-30, 2005.

5. Khasawneh, F.T., Huang, J., Turek, J., and Le Breton, G.C., “Differential Mapping of The Amino Acids Mediating Agonist and Antagonist Coordination with the Human Thromboxane A2

Receptor Protein,” Poster Presentation, The 46th Annual meeting of the American Society of Hematology, Atlanta, Georgia, December 4-7, 2005.

6. Khasawneh, F.T., Huang, J., Turek, J., and Le Breton, G.C., “Amino Acids Participating in the Human Thromboxane A2 Receptor Agonist and Antagonist Interaction Process,” Poster Presentation, College of Medicine Student Medical Research Forum, University of Illinois at Chicago, Chicago, February 1, 2006.


Receptor Protein,” Poster Presentation, 19th Annual Scientific Meeting of the Great Lakes Chapter-American Society for Pharmacology and Experimental Therapeutics, University of Illinois at Chicago, Chicago, Illinois, June 9, 2006.


Receptor Protein,” Poster Presentation, 2006 International Conference, Frontiers of Pharmacology and Toxicology, Chicago, Illinois, August 28-31, 2006.

9. Khasawneh, F. T., Huang, J., Turek, J., and Le Breton, G.C., “Characterizing the Coordination Forces Between the Human Thromboxane A2 Receptor and its Ligand Pharmacophores,” 11th

Biennial Midwest Platelet Conference, Chicago, Illinois, October 5-8, 2006.10. Khasawneh, F.T., Huang, J., Tiruppathi, C., and Le Breton, G.C., “8-iso-PGF2α is a Potent

Agonist for the Human Thromboxane A2 Receptor with a Unique Ligand Binding Profile,” 11th

Biennial Midwest Platelet Conference, Chicago, Illinois, October 5-8, 2006.11. Khasawneh, F.T., Huang, J., Tiruppathi, C., and Le Breton, G.C., “Molecular Characterization

of the 8-iso-PGF2α Interaction with the Human Thromboxane A2 Receptor and its Signaling Mechanisms in Human Platelets,” Experimental Biology Annual Meeting, Washington, DC, April 28–May 2, 2007.

12. Khasawneh, F.T., Huang, J., Tiruppathi, C., and Le Breton, G.C., “Evidence for the Presence of a Novel Gs-coupled Isoprostane Receptor in Human Platelets,” Poster Presentation, College of Medicine Student Medical Research Forum, University of Illinois at Chicago, Chicago, February 7, 2007.

13. Khasawneh, F.T. and Le Breton, G.C., “Evidence for the Presence of a Novel Gs-coupled Isoprostane receptor in Human Platelets,” Poster Presentation, The 38th Annual Midwest Student Biomedical Research Forum, University of Nebraska Medical Center, Omaha, Nebraska, February 23-24, 2006.

14. Khasawneh, F.T. and Le Breton, G.C., “Evidence for the Presence of a Novel Gs-coupled Isoprostane Receptor in Human Platelets,” The 20th Annual Scientific Meeting of the Great Lakes Chapter of the American Society for Pharmacology and Experimental Therapeutics, Rosalind Franklin University, North Chicago, Illinois, June 8, 2007.

15. Gussin, H.A., Khasawneh, F.T., Xie, A., Qian, H., Le Breton, G.C., Pepperberg, D.R., “Characterization of a Novel Polyclonal Anti Human 1 GABAC Antibody, “ The 2008 Annual Meeting of The Association for Research in vision and Ophthalmology, Fort Lauderdale, Florida, April 27- May 1, 2008.

16. Srinivasan, S., Mir, F., Huang, J., Khasawneh, F.T., Huang, J., Lam, S., and Le Breton, G.C., “The adenosine-based P2Y12 antagonist, 2MeSAMP inhibits human platelet aggregation through a Gi-independent increase in platelet cAMP levels,” 12th Biennial Midwest Platelet Conference, Lexington, Kentucky, October 2-4, 2008.

17. Ting, H.J, and Khasawneh, F.T., “A Novel Antagonist for the Thromboxane A2 Receptor”. EB 2010 Meeting, April 25, 2010

18. Ting, H.J, and Khasawneh, F.T., “Drug Rediscovery: Glybenclamide Exhibits Thromboxane Receptor Dependent Antithrombotic Activity”. EB 2010 Meeting, April 25, 2010

19. Murad, J.P., Ting, H.J, and Khasawneh, F.T., “A Novel Antagonist for the Thromboxane A2

Receptor”. Tobacco-Related Disease Research Symposium, University of California Riverside, October 29, 2010

20. Murad, J.P., Ting, H.J, and Khasawneh, F.T., “The Transient Receptor-Potential Channel 6 Plays a Critical Role in Platelet Function”. Western University Research Day, Western University of Health Sciences, March 25, 2011.


21. Morris, D., Franklin, M., Ho, H., Khurasany, M., Guilford, T., Khasawneh, F.T., and Venketaraman, V. “Unveiling the Mechanisms for Decreased GSH in Individuals With HIV Infection”. Southern California Academy of Sciences Annual Meeting, May 6-7, 2011

22. Murad J.P., Espinosa E.V., Ting H.J., and Khasawneh F.T., “Targeting the Ligand-Binding Domain of the Platelet Thromboxane A2 receptor for Therapeutic Interventions” Linking Tobacco Control Research and Practice for a Healthier California Meeting, Tobacco-Related Disease Research Program, University of California Office of the President, Sacramento CA, April 10-12, 2012

23. Paez Espinosa, EV., Murad, J.P., Ting, H.J., and Khasawneh F.T., “Transient Receptor Potential Channel 6: Role in Hemostasis and Thrombogenesis”, Experimental Biology 2012 Meeting, San Diego, CA, April 25 2012

24. Murad J.P., Espinosa E.V., Ting H.J., and Khasawneh F.T., “A Novel Antithrombotic Agent Targeting the Human Thromboxane A2 Receptor”, Experimental Biology 2012 Meeting, San Diego, CA, April 25 2012

25. Murad J.P., Espinosa E.V., Ting H.J., and Khasawneh F.T., “Targeting the Ligand-Binding Domain of the Platelet Thromboxane A2 receptor for Therapeutic Interventions”, 14th Biennial Midwest Platelet Conference, Cleveland, Ohio, October 18-19, 2012.

26. Lin, O.A, Espinosa E.V., and Khasawneh F.T., “The 5-HT2A Receptor Antagonists Pizotifen and Cyproheptadine Inhibit Serotonin-enhanced Platelet Function”, Experimental Biology 2013 Meeting, Boston, MA, April 23 2013

27. Vemana H.P., Karim Z.A., Lin, O.A., and Khasawneh F.T.,”A Critical Role for the Transient Receptor Potential Channel Type 6 in Human Platelet Activation”, Hemostasis Gordon Research Conference, Waterville Valley, NH, July 27-August 1 2014.

28. Alshehri A.M., Karim Z.A., Vemana H.P., Lin, O.A., and Khasawneh F.T.,”A Novel Function Blocking Antibody Targeting the ADP P2Y1 Receptor Protein”, College of Pharmacy Poster Day, Western University of Health Sciences, Pomona, CA, May 8 2014.

29. Karim Z.A., Espinosa E.V.P., Lin O.A., Vemana H.P., Murad J.P., and Khasawneh F.T., “The Transient Receptor-Potential Channel 6: Modulation of Platelet Function By Regulation of the Thromboxane A2 Receptor-Operated Calcium Entry”, 15th Biennial Midwest Platelet Conference, Chicago, IL, October 8-10, 2014.

30. Khasawneh F.T., Vemana H.P., and Karim, Z.A. “A Novel MALT1-Ubiquitination Pathway Regulates Non-Genomic NF-B/IKK Signaling in Platelets”, 15th Biennial Midwest Platelet Conference, Chicago, IL, October 8-10, 2014.

31. Karim Z.A., Vemana H.P., Lin O.A., Alshehri A.M., Javaherizadeh P., Espinosa E.V.P., Murad J.P., and Khasawneh F.T., “Characterization of a Novel Function-Blocking Antibody Targeted Against The Platelet P2Y1 Receptor”, 15th Biennial Midwest Platelet Conference, Chicago, IL, October 8-10, 2014.

32. Vemana H.P., Karim Z.A., Conlon C., and Khasawneh F.T.,”A New Player In Platelet Function”, Experimental Biology 2015 Meeting, Boston, MA, March 29 2015

33. Karim Z.A., Alshbool F.Z., Vemana H.P., Adhami N., Dhall S., Lin O.A., Espinosa E.V.P, Martins-Green M., and Khasawneh F.T. ”Third Hand Smoke: Impact on Hemostasis and Thrombogenesis”. Cell Biology of Megakaryocytes & Platelets, Gordon Research Conference, April 19-24 2015, Lucca (Barga), Italy.

33. Karim Z.A., Alshbool F.Z., Vemana H.P., Adhami N., Dhall S., Lin O.A., Espinosa E.V.P, Martins-Green M., and Khasawneh F.T., “Third Hand Smoke: Impact on Hemostasis and Thrombogenesis” Translational Nicotine Research Group Symposium, June 26 2015, University of California Los Angeles, Los Angeles, CA.

34. Hensch N.R., Karim Z.A. and Khasawneh F.T.,” Antibody Targeted Against P2Y12 Receptor Reduces Platelet Activity In vitro and In vivo”, Experimental Biology 2016 Meeting, San Diego, CA, April 4 2016.

35. Karim Z.A., Lin O.A., and Khasawneh F.T.,”The First Intracellular Loop Regulates The Platelet Thromboxane A2 Receptor-Gq-Dependent Signaling And Function”, Experimental Biology 2016 Meeting, San Diego, CA, April 4 2016.

36. Karim Z.A., Venkatesan N., Hensch, N.R., Ting, H.J, Betageri G., and Khasawneh, F.T., “Characterization of a Liposome-Based Formulation for Clopidogrel”, Hemostasis Gordon Research Conference, Stoweflake, VT, July 24 - July 29 2016.


37. Karim Z.A., Hensch, N.R., and Khasawneh, F.T., “Essential role for IB Kinase in remodeling CARMA1/Bcl10/MALT1 complexes in activated platelets”, Hemostasis Gordon Research Conference, Stoweflake, VT, July 24 - July 29 2016.

Oral/Invited Presentations1. Khasawneh, F.T. and Le Breton, G.C., “Identification of the Amino Acids Involved in Ligand

Binding to the Human Thromboxane A2 Receptor Protein,” 10th Biennial Midwest Platelet Conference, Milwaukee, Wisconsin, October 8-10, 2004.

2. Khasawneh, F.T. and Le Breton, G.C., “Differential Mapping of The Amino Acids Mediating Agonist and Antagonist Coordination with the Human Thromboxane A2 Receptor Protein,” The 47th Annual National Student Research Forum, University of Texas Medical Branch, Galveston, Texas, April 27-28, 2006.

3. Khasawneh, F.T. and Le Breton, G.C., “Molecular Characterization of Isoprostanes Signaling and Biological Effects: Evidence for the Presence of a Novel Gs-coupled Receptor in Human Platelets,” The 48th Annual National Student Research Forum, University of Texas Medical Branch, Galveston, Texas, April 26-27, 2007.

4. Khasawneh, F.T., Huang, J., Tiruppathi, C., and Le Breton, G.C., “Molecular Characterization of the 8-iso-PGF2α Interaction with the Human Thromboxane A2 Receptor and its Signaling Mechanisms in Human Platelets,” American Society for Pharmacology and Experimental Therapeutics, Cardiovascular Division Best Abstract Competition Forum, EB 2007, Washington, DC, April 30, 2007.

5. Ting, H.J, and Khasawneh, F.T., “Drug Rediscovery: Glybenclamide Exhibits Thromboxane Receptor Dependent Antithrombotic Activity” Cardiovascular III, 2010 Western Regional Meeting, January 2010.

6. Murad J.P., Espinosa E.V., Ting H.J., Khasawneh F.T., “A Novel Antithrombotic Agent Targeting the Human Thromboxane A2 Receptor”, Cardiovascular Pharmacology Division Trainee Showcase, Experimental Biology 2012 Meeting, San Diego, CA, April 24 2012

7. Khasawneh F.T., “Characterization of a Novel Antagonist for the Human Platelet Thromboxane A2 Receptor”, 3rd International Conference on Biomarkers & Clinical Research, Las Vegas, Nevada, July 2-4 2012.

8. Khasawneh F.T., “Targeting the Ligand-Binding Domain of the Platelet Thromboxane A2

receptor for Therapeutic Interventions”, 14th Biennial Midwest Platelet Conference, Cleveland, Ohio, October 18-19, 2012.

9. Khasawneh F.T., “The Transient Receptor-Potential Channel 6 Regulates Thromboxane A2

Receptor-Operated Calcium Entry and Plays a Critical Role in Platelet Function”, Arteriosclerosis, Thrombosis, and Vascular Biology 2013 Meeting, Lake Buena Vista, Florida (May 1-3, 2013).

10. Khasawneh F.T., “The Transient Receptor-Potential Channel 6: Modulation of Platelet Function By Regulation of the Thromboxane A2 Receptor-Operated Calcium Entry”, 15th

Biennial Midwest Platelet Conference, Chicago, IL, October 8-10, 2014.11. Khasawneh F.T., “Grant Writing 101- Part I”, A Faculty Development Activity Organized by

the Faculty Orientation and Development Committee. College of Pharmacy, Western University of Health Sciences, February 11, 2016.

BOOK CHAPTERS

1. Morris D., Donohou C., Sipin A., Kung S., Franklin M., Murad J.P., Khasawneh F.T., Saviola B, Guilford T and Venketaraman V, “Role of cytokines and chemokines in HIV infection” in the book entitled " HIV and AIDS - Updates on Biology, Immunology, Epidemiology and Treatment Strategies", ISBN 978-953-307-665-2. INTECH, Open Access Publisher, 2011

SPONSORED RESEARCH/FUNDING

Extramural o CurrentNone


o Forfeited/Returned to Funding Agency Principal Investigator, Investigation of Platelet G-protein Coupled Receptors*, NIH

Academic Research Enhancement Award (AREA) Grant Program (Parent R15; 2R15HL115567-02), National Institutes of Health, May 23, 2016 – April 30, 2019; Total costs: $420,660.

Co-Investigator, Regulation of Platelet SNARE Machinery*, NIH Academic Research Enhancement Award (AREA) Grant Program (Parent R15; 1R15HL127592-01A1), National Institutes of Health, (February 12, 2016 – January 31, 2020); Total costs: $421,946.

Principal Investigator, Third-Hand Smoke Impact on Platelet Function and Thrombosis**, High Impact Research Project Award (392764), Tobacco-Related Disease Research Program, July 1, 2016 - June 30, 2018; Total costs $427,235.

* PI was not allowed to transfer the grant after relocation** PI was not allowed to transfer the grant after relocation to a different State

o Completed Principal Investigator, Investigating the Role of Transient Receptor Potential Channel 6

in Platelet Function, Grant-In-Aid (14GRNT20450127), The American Heart Association, Western States Affiliate, July 1, 2014 - June 30, 2016; no-cost extension till December 31 2016); Total costs: $140,000.

Principal Investigator, Investigation of Platelet G-protein Coupled Receptors, NIH Academic Research Enhancement Award (AREA) Grant Program (Parent R15; 1R15HL115567-01A1), National Institutes of Health, July 8, 2013 – May 22, 2016; Total costs: $416,976.

Principal Investigator, Characterization of Platelet Thromboxane Receptors, New Investigator Award (19KT-0030), Tobacco-Related Disease Research Program, July 1, 2010 - June 30, 2013; No-cost extension June 30, 2014, Total costs $277,422.

Principal Investigator, Mapping of a ligand binding domain for the human Thromboxane A2 receptor protein, Predoctoral Fellowship (0515533Z), The American Heart Association, July 1, 2005 - June 30, 2007, Total costs $52,000.

PENDING: Principal Investigator, Investigating the Role of The Regulator of G-Protein Signaling 16

in Platelet Function, Grant-In-Aid (16GRNT31350032), The American Heart Association, July 1, 2017 – June 30, 2019); Total costs: $154,000. (Submitted Feb 16 2017)

Principal Investigator, Investigation of RGS Regulation and Signaling, Research Project Grant (R01; 1 R01 GM125988-01), NIGMS, NIH, (submitted February 3 2017); Total costs: $ 1,887,500.00

Co-Investigator, Regulation of Platelet SNARE Machinery, Research Project Grant (R01; 1 R01 GM125987-01), NIGMS, NIH, (submitted February 4 2017); Total costs: $ 1,887,500.00

Principal Investigator, The Impact of Third-Hand Smoke on Platelet Function and Thrombogenesis, Research Project Grant (R01; 1R01ES027036-01A1), NIEHS, NIH, (submitted November 2 2016); Total costs: $1,912,679.00

Intramural o CurrentNone

o Completed Co-Principal Investigator, Randomized controlled trial for determination of efficacious

black cohosh dose and identification of its potential active components in patients with postmenopausal vasomotor symptoms – a pilot study, Intramural Research Grant, Western University of Health Sciences, July 1, 2010 - June 30, 2011, $18,000.

Principal Investigator, Characterization of the Anti-platelet Effects of Novel Aspirin Analogs, Intramural Research Grant, Western University of Health Sciences, July 1, 2009-June 30 2010, $20,000.


Principal Investigator, Characterization of the 8-iso-PGF2α isoprostane signaling and biological functions in human platelets, 2006 Deiss Award in Biomedical Research, The Graduate College, University of Illinois at Chicago, September 2006 - June 2007, $1,825.

PATENTS

Co-Inventor: RHO1-Gamma Amino Butyric Acid C Receptor-Specific Antibodies. Status: Pending (Pub. No.: US 2009/0269786 A1, Pub Date: 10/29/2009).

Co-Inventor: Peptides and methods for inhibiting Galpha protein signaling. Status: Issued (No.: 8575103; Issue Date: 11/05/2013).

TEACHING

Graduate Courses Taught PHSC 5101 Advanced Pharmaceutical Sciences I Fall ‘08 PHSC 5101 Advanced Pharmaceutical Sciences I (Course Facilitator) Fall ‘09 PHSC 6302 Advanced Pharmacology (Course Facilitator) Fall ‘09 PHSC 5101 Advanced Pharmaceutical Sciences I Fall ‘10 PHSC 6000 Graduate Seminar (Journal Club) (Course Facilitator) Fall ‘10 PHSC 6000 Graduate Seminar (Journal Club) (Course Facilitator) Spring ‘11 PHSC 6302 Advanced Pharmacology (Course Facilitator) Fall ‘11 PHSC 6901 Research Techniques: Theory and Practice (Course Facilitator) Spring ‘12 PHSC 5101 Advanced Pharmaceutical Sciences I Fall ‘12 PHSC 6302 Advanced Pharmacology (Course Facilitator) Spring ‘13 PHSC 5101 Advanced Pharmaceutical Sciences I Fall ‘13 PHSC 6901 Research Techniques: Theory and Practice (Course Facilitator) Spring ‘14 PHSC 5101 Advanced Pharmaceutical Sciences I Fall ‘14 PHSC 6000 Graduate Seminar (Journal Club) (Course Facilitator) Fall ‘14 PHSC 5101 Advanced Pharmaceutical Sciences I Fall ‘15 PHSC 6901 Research Techniques: Theory and Practice (Course Facilitator) Spring ‘16 PHSC 5101 Advanced Pharmaceutical Sciences I Fall ‘16

Undergraduate Courses Taught PHRM 5224 Pharmacological Basis of Therapeutics IV Spring ‘08 PHRM 5221 Pharmacological Basis of Therapeutics I (Course Facilitator) Fall ‘08 PHRM 5222 Pharmacological Basis of Therapeutics II (Course Co-Facilitator) Fall

‘08 PHRM 5224 Pharmacological Basis of Therapeutics IV Spring ‘09 PHRM 5221 Pharmacological Basis of Therapeutics I (Course Facilitator) Fall ‘09 PHRM 5222 Pharmacological Basis of Therapeutics II Fall ‘09 PHRM 5224 Pharmacological Basis of Therapeutics IV Spring ‘10 PHRM 5221 Pharmacological Basis of Therapeutics I (Course Facilitator) Fall ‘10 PHRM 5222 Pharmacological Basis of Therapeutics II Fall ‘10 PHRM 5221 Pharmacological Basis of Therapeutics I (Course Facilitator) Fall ‘11 PHRM 5222 Pharmacological Basis of Therapeutics II Fall ‘11 PHRM 5221 Pharmacological Basis of Therapeutics I (Course Facilitator) Fall ‘12 PHRM 5222 Pharmacological Basis of Therapeutics II Fall ‘12 PHRM 5221 Pharmacological Basis of Therapeutics I (Course Facilitator) Fall ‘13 PHRM 5222 Pharmacological Basis of Therapeutics II Fall ‘13 PHRM 5221 Pharmacological Basis of Therapeutics I (Course Facilitator) Fall ‘14 PHRM 5222 Pharmacological Basis of Therapeutics II Fall ‘14 PHRM 5221 Pharmacological Basis of Therapeutics I (Course Facilitator) Fall ‘15 PHRM 5222 Pharmacological Basis of Therapeutics II Fall ‘15 PHRM 5221 Pharmacological Basis of Therapeutics I (Course Facilitator) Fall ‘16

POST-DOCTORAL MENTORING Zubair A. Karim, Ph.D. (June 2013 - present)


Enma (Veronica) Paez Espinosa, M.D., Ph.D. (March 2011 - April 2013) Amir Zargarzadeh, Pharm.D. (October 2010 - Januray 2011)

GRADUATE STUDENT ADVISING Master’s Students ( 1 Current, 4 Graduated ) Harold J. Ting (Fall 2010). Characterization of the Antiplatelet Activity of the Antidiabetic

Agent Glybenclamide. Jasmine Saavedra (Masters of Science in Medical Sciences; Spring 2011). Investigation of the

Drug-Drug Interaction Between Plavix® and Proton-Pump Inhibitors. John Murad (Spring 2012). Characterizing the Antiplatelet and Antithrombotic Activity of an

Antibody Targeting the Human Platelet Thromboxane A2 Receptor. Olivia Lin (Fall 2013). The Antidepressant 5-HT2A Receptor Antagonists Pizotifen and

Cyproheptadine Inhibit Serotonin-Enhanced Platelet Function Hari Priya Vemana (Spring 2015). A Critical Role for the Transient Receptor Potential Channel

Type 6 in Human Platelet Activation. Nicole Hensch (Spring 2017). Characterizing the Antiplatelet and Antithrombotic Activity of

an Antibody Targeting the Human Platelet P2Y12 Receptor

MS Thesis Committee Member/Adjunct Member Sravan Penchala (December 2008). “Synthesis, Identification, Characterization and in vitro

Evaluation of Novel Aspirin Analogs as Potential Chemopreventive Agents for Colorectal Cancer.” Advisor, Dr. Jeffery Wang

Drupad U. Parikh (December 2009). “The Role of Endogenous Opioid System in Regulation of Nociception and Reward.” Advisor, Dr. Kabir Lutfy

Dhruvitkumar Sutaria (December 2010). “Chemoprevention of Pancreatic Cancer using Solid Lipid Nanoparticles." Advisor, Dr. Sunil Prabhu.

Andy Tseng (August 2012). “The Role of Endogenous Beta-Endorphin and Enkephalins in Ethanol Reward.” Advisor, Dr. Kabir Lutfy.

Justin Moussata (January 2013). “Indole-3-Carbinol Acetate As a Potential Chemopreventive Agent For Breast Cancer”. Advisor. Dr. Jeffrey Wang.

Mayank Garg (July 2013) “The Role of Orphanin FQ/Nociceptin and Its receptor in Cocaine-Induced Conditioned Place Preference, Its Extinction and Reinstatement”. Advisor: Dr. Kabir Lutfy

Sarala Yanamandra (July 2013). “Proliposomal formulation of poorly water soluble drug lovastatin: in-vitro and in-vivo evaluation”. Advisor: Dr. Guru Betageri.

Jenny Nguyen, M.S., “Identification of the binding partners of GRK4γ: an approach to understand the molecular mechanisms of GRK4γ action”, Advisor: Dr. Bradley Andresen (December 2014)

Anita Ahoura, M.S., “Sugar Reinforcement: Involvement of Neuropeptides”, Advisor: Dr. Kabir Lutfy (September 2015)

Prableen Singh, M.S., “Nicotine’s Effect on the acquisition, extinction, reinstatement of Cocaine CPP: Role of Beta-Endorphin and Gender”, Advisor: Dr. Kabir Lutfy (September 2015)

Abdelaziz Alsamarah, M.S., “Computational study of ALK2 protein kinase: molecular mechanism of inhibition and activation”, Advisor: Dr. Lyna Luo (December 2016)

Rhye-Samuel Kanassatega, M.S., “Structure, interactome & functional Analysis of G-protein coupled receptor kinase 4”, Advisor: Dr. Bradley Andresen (January 2016)

AWARDS AND HONORS

Harriet K. and Philip Pumerantz Award for Leadership and Service, Western University of Health Sciences, August 8, 2015.

Teacher of the Year Award, College of Pharmacy, Western University of Health Sciences, April 2, 2015.

Faculty Service Award, College of Pharmacy, Western University of Health Sciences, April 2, 2015.


Finalist, the Kenneth M. Brinkhous Young Investigator Prize in Thrombosis, Arteriosclerosis, Thrombosis, and Vascular Biology 2013 Meeting, Lake Buena Vista, Florida (May 1 - 3, 2013)


Third Place, Hot Topics Oral Abstract Presentations, 14th Biennial Midwest Platelet Conference, Cleveland, Ohio (October 18 - 19, 2012)

(MS Candidate John Murad winner of) First Place, The Graduate Student Best Abstract Award, Division for Cardiovascular Pharmacology, American Society for Pharmacology and Experimental Therapeutics, Experimental Biology Meeting, San Diego, CA (April 21 - April 2, 2012)


Young Scientist Travel Award. American Society for Pharmacology and Experimental Therapeutics, Experimental Biology Meeting, Anaheim, CA (April 24 - April 28, 2010)

Inductee, Cambridge Who’s Who among Executives, Professionals and Entrepreneurs (February 2009)

Nominee, Who’s Who in America (Marquis' Version; November 2008) Predoctoral Fellowship, The American Heart Association, (2005 - 2007) Second Place Poster Presentation, Postdoctoral Fellow Category, The 20th Annual

Scientific Meeting of the Great Lakes Chapter of the American Society for Pharmacology and Experimental Therapeutics, Illinois (June 8, 2007)

Graduate Student Travel Award, American Society for Pharmacology and Experimental Therapeutics, Experimental Biology Meeting, Washington, DC (April 28 - May 2, 2007)

First Place, The Graduate Student Best Abstract Award, Division for Cardiovascular Pharmacology, American Society for Pharmacology and Experimental Therapeutics, Experimental Biology Meeting, Washington, DC (April 28 - May 2, 2007)

Student Medical Research Forum Winner, The Forty Fifth College of Medicine Honors Day, MD/PhD & PhD Category, University of Illinois at Chicago (April 18, 2007)

Nominee for Eugertha Bates Service Award, University of Illinois at Chicago (April 2007) Second Place Award in Poster Presentation, The 38th Annual Midwest Student

Biomedical Research Forum, Graduate Student Category, University of Nebraska Medical Center, Omaha, Nebraska (February 23, 2007)

First Place, Student Medical Research Forum, MD/PhD & PhD Category, College of Medicine, University of Illinois at Chicago (February 7, 2007)

Activities Honorary Society Membership Award, University of Illinois Alumni Association (April 15, 2007)

University of Illinois Alumni Association Leadership Award, University of Illinois at Chicago (March 15, 2007)

Chancellor’s Student Service Award, University of Illinois at Chicago (April 2007) Deiss Award in Biomedical Research, The Graduate College, University of Illinois at

Chicago (October 27, 2006) First Annual NIH National Graduate Student Research Festival Travel Award,

Bethesda, Maryland (October 10 - 12, 2006) The Albert and Doris Woeljten Award for Outstanding Research Achievements as a

Graduate Student, Department of Pharmacology Annual Retreat, University of Illinois at Chicago (September 14, 2006)

Who’s Who Among Students in American Universities and Colleges (2006) Second Place Poster Presentation, 19th Annual Scientific Meeting of the Great Lakes

Chapter of the American Society for Pharmacology and Experimental Therapeutics, Graduate Student Category, University of Illinois at Chicago (June 9, 2006)

First Place Award for Overall Oral Presentation, The National Student Research Forum, The University of Texas Medical Branch, School of Medicine, Office of Student Affairs (April 28, 2006)

Chancellor’s Student Service Award, University of Illinois at Chicago (April 24, 2006) First Place, 2006 Sigma Xi Science Graduate Student Research Forum, University of Illinois

at Chicago (April 21, 2006) International Student Service Award, Scholarship Association for UIC, University of

Illinois at Chicago (April 7, 2006)Fadi T. Khasawneh – of 17

Second Place, Student Medical Research Forum, MD/PhD & PhD Category, College of Medicine, University of Illinois at Chicago (February 1, 2006)

Graduate Student Council Travel Award, University of Illinois at Chicago (January, 2006) Graduate College Travel Award, University of Illinois at Chicago (January, 2006). Travel Grant, Cayman Chemical, Inc. (December, 2005) The Albert and Doris Woeljten Best Poster Award, First Place, Department of

Pharmacology Annual Retreat, University of Illinois at Chicago (September 30, 2005) Second Place, Student Medical Research Forum, MD/PhD & PhD Category, College of

Medicine, University of Illinois at Chicago (February 2, 2005) 10th Biennial Midwest Platelet Conference Travel Award, Milwaukee, Wisconsin

(October 8-10, 2004) The Albert and Doris Woeljten Best Poster Award, Second Place, Department of

Pharmacology Annual Retreat (September 17, 2004) Queen Rania Al-Abdullah Award for Academic Excellence, Jordan University of Science

and Technology, Irbid, Jordan (2000) Dean’s Honor List for Academic Excellence, Jordan University of Science and

Technology, Irbid, Jordan (Three Semesters 1997-1999)

COLLOQUIUMS, COURSES, CERTIFICATES, WEBINARS AND WORKSHOPS American Association of Colleges of Pharmacy 2016 Leadership Forum, Strategic Planning,

Gaylord Opryland Resort and Convention Center, Nashville, Tennessee March 29-April 1, 2016.

Campus Master Plan Leadership Summit, Western University of Health Sciences, March 7, 2016.

Avoid the Courtroom: Conducting Effective Internal Investigations, The Center for Academic and Professional Enhancement, February 18, 2016, Western University of Health Sciences.

Behavioral Interviewing seminar, The Center for Academic and Professional Enhancement, February 17, 2016, Western University of Health Sciences.

American Association of Colleges of Pharmacy 2015 Leadership Forum, Creative and Innovative Leadership, Hilton Anaheim, Anaheim, California, March 18-21, 2015.

American Association of Colleges of Pharmacy 2014 Leadership Retreat, Gaylord National, National Harbor, Maryland, March 20 - 22 2014.

American Association of University Professors (AAUP) Summer Institute, Seattle, WA, July 25-28, 2013, University of Washington.

Leadership for Institutional Effectiveness, AACP Interim Meeting. Rio Grande, Puerto Rico, February 9-12, 2013

Assessment Institute. Indianapolis, IN, October 29 - 30, 2012 Meeting Magic: Facilitation & Planning Skills for Meeting Productivity (Webinar), Ascentis

Corp. November 29, 2012 Motivating Students: Four Steps to Dynamic Classes (Webinar). The Center for Academic and

Professional Enhancement, June 26 2012, Western University of Health Sciences. “Academic Technology for Effective Course Design and Instruction” workshop, The Center for

Academic and Professional Enhancement, March 21 2011, Western University of Health Sciences.

“Developing a Faculty-Centered Performance Evaluation” workshop, The Center for Academic and Professional Enhancement, March 10 2011, Western University of Health Sciences.

“Active Learning and the Pedagogical Change”, 2010 AACP Institute, May 24 - 26, 2010, National Conference Center, Lansdowne, VA.

“Writing Effective Multiple Choice Questions” workshop, The Center for Academic and Professional Enhancement, November 2009, Western University of Health Sciences.

Microvascular Hemodynamic Surgery and Survival Surgery Techniques, Wake Forest University School of Medicine, Winston-Salem, NC, July 13 - 15 2009

“How to Write Exam Questions” workshop, College of Pharmacy, Western University of Health Sciences, June 11 2009

Evidence-Based Medicine for Basic-Science Faculty, College of Pharmacy, April 17 2009, Western University of Health Sciences.


“Pathways to NIH Awards” workshop, The Center for Academic and Professional Enhancement, March 2009, Western University of Health Sciences.

Protecting Human Research Participants, Web-Based Training Course, September 26, 2008. Enhancing Your Facilitation Skills, The Center for Academic and Professional Enhancement,

September 16, 2008, Western University of Health Sciences. Foreign Pharmacy Graduate Equivalency Certificate (FPGEC; Certified July 30, 2008) Academic Boot Camp 6, “How to Design a Course Portfolio”, The Center for Academic and

Professional Enhancement, July 7 - 9, 2008, Western University of Health Sciences. 3rd RGS Protein Colloquium, San Diego, California, April 4 - 5, 2008. Toxicology in Drug Development, A Continuing Education Course, Frontiers of Pharmacology

and Toxicology Conference, Chicago, Illinois (August 26 - 27, 2006). Strategies for Effective Scientific Communication, University of Illinois at Chicago, Chicago,

Illinois, August, 2004. Essentials for Animal Research, University of Illinois at Chicago (August 2003).

SCIENTIFIC AND PROFESSIONAL SOCIETY MEMBERSHIPS

Member, Association of Jordanian Pharmacists (since 02/1999) Member, The Honor Society of Phi Kappa Phi (since 04/2005) Member, The Scientific Research Society, Sigma Xi (since 08/2005) Member, The American Heart Association (since 09/2005) Member, The American Society for Pharmacology and Experimental Therapeutics (since

08/2006) Member, American Association for the Advancement of Science (AAAS; since 2008) Member, American Association of Colleges of Pharmacy (since 01/2009) Member, The American Society of Hematology (since 04/2009) Honorary Member, Kappa Psi Pharmaceutical Fraternity (Since 2/2010) Honorary Member, The Rho Chi Society (Since 3/2013)

COMPUTER SKILLS

Operating Systems : Windows NT/98/2000/XP/2003/Vista General Applications : Microsoft Office: MS Word, PowerPoint and Excel Statistical Analysis : GraphPad Prism Software Graphics : Adobe Photoshop CS6

INSTITUTIONAL AND PROFESSIONAL ACTIVITIES/SERVICES

THE UNIVERSITY OF TEXAS AT EL PASO UNIVERSITY

Member, Faculty Senate, The University of Texas at El Paso, (December 1 - Present).

COLLEGE/DEPARTMENT Member, Leadership Team, School of Pharmacy, The University of Texas at El Paso,

(October 17 2016 – Present) Member, Student Excellence Team & Admissions Subcommittee, School of

Pharmacy, The University of Texas at El Paso, (November 21 2016 – Present) Ex Officio Member, Faculty Excellence Team, School of Pharmacy, The University of

Texas at El Paso, (November 21 2016 – Present) Ex Officio Member, Curriculum Committee, School of Pharmacy, The University of

Texas at El Paso, (November 21 2016 – Present) Ex Officio Member, Research and Scholarship Committee, School of Pharmacy, The

University of Texas at El Paso, (November 21 2016 – Present) Member, Assessment Committee, School of Pharmacy, The University of Texas at El

Paso, (November 21 2016 – Present)

WESTERN UNIVERSITY OF HEALTH SCIENCES Fadi T. Khasawneh – of 17

UNIVERSITY Member, College of Podiatric Medicine Self-study Committee for Standard 5

(Faculty), Western University of Health Sciences, (August 25 2015 – March 2016) Chair, Research Committee, Western University of Health Sciences, (July 2015 – June

2016); Member, Research Committee, Western University of Health Sciences, (August 2011 – June 2015)

Member, Presidential Search Advisory Committee, Western University of Health Sciences, (April 3rd 2015 – February 2016).

Past Chair, Academic Senate, Western University of Health Sciences, (July 1 2015 - June 30 2017); Chair, Academic Senate, Western University of Health Sciences, (July 1 2013 - June 30 2015); Vice-Chair (Chair-Elect), Academic Senate, Western University of Health Sciences, (March 2012 - June 30 2013); Member, Academic Senate, Western University of Health Sciences, (August 1 2010 - February 2012).

Vice Chair, Institutional Animal Care and Use Committee (IACUC), Western University of Health Sciences, July 2015 – June 2016; Member, Institutional Animal Care and Use Committee (IACUC), Western University of Health Sciences, (December 2011 - June 30 2015); Alternate Member for the College of Pharmacy, Institutional Animal Care and Use Committee (IACUC), Western University of Health Sciences, (July 2009 - December 2011).

Member, CRO Support Team, Western University of Health Sciences, (July 1, 2015 – March 2016).

Chair, Ballot Committee, Western University of Health Sciences, (July 1 2015 – June 30 2016).

Member, University Policy Committee, Western University of Health Sciences, (May 6 2015 –June 30 2016)

Member (ad hoc), Promotion & Tenure Committee, College of Graduate Nursing, Western University of Health Sciences, (February 25 2015 - present).

Chair, Contracts Task Force, Western University of Health Sciences (October 2014 – June 30 2016)

Member, Emergency Management Committee, Western University of Health Sciences, (December 5 2013 – June 30 2016)

Member, Western Association of Schools & Colleges (WASC) Steering Committee, Western University of Health Sciences, (November 2013 - October 2014)

Member, Space Planning Committee, Western University of Health Sciences, (October 2013 - present)

Chair, University Faculty Affairs Committee, Western University of Health Sciences, (September 2013 – June 30 2016)

Member, Portal Strategic Planning Subgroup, Western University of Health Sciences, (September 2013 - July 2014)

Member, Diversity Strategic Planning Subgroup, Western University of Health Sciences, (September 2013 – November 2014)

Member, Education Strategic Planning Implementation Group, Western University of Health Sciences, (June 2013 - November 2014)

Member, Internal Fitness Strategic Planning Implementation Group, Western University of Health Sciences, (June 2013 - June 2014)

Elected Member, University Grievance Committee, Western University of Health Sciences, (Academic year 2012-2013)

Member, Ballot Committee, Western University of Health Sciences, (March 2012 - June 30 2015).

Member, Faculty Handbook Committee (Ad Hoc), Academic Senate, Western University of Health Sciences, (April 2011 - August 2013)

Appointed Member, University Research Space Committee, Western University of Health Sciences, (March 2010 - July 2011)

Facilitator, Interprofessional Education (IPE), Western University of Health Sciences, (January 13 2010 - present)

Elected Member, University Grievance Committee, Western University of Health Sciences, (Academic year 2009 - 2010)


Member of the 2007 Graduate and Professional Research Forum Committee, Office of the Vice Chancellor for Research, The University of Illinois at Chicago (April 20, 2007)

Search Committee Member, Student Affairs Specialist, Office of the Dean of Students, The University of Illinois at Chicago (January 23, 2007)

Graduate Student Council Vice President, The University of Illinois at Chicago (Academic Year 2006 - 2007)

Graduate Student Senator, The University of Illinois at Chicago Senate, Member of the Executive (Academic Year 2005 - 2006), Student Affairs (Academic Years 2005 - 2006 & 2006 - 2007), and Research Committees (Academic Year 2006 - 2007)

Graduate Student Council Representative, Department of Pharmacology, University of Illinois at Chicago (Academic Year 2005 - 2006)

Volunteer, Graduate Admissions Office, Integrated Graduate Program in Biomedical Sciences, College of Medicine, University of Illinois at Chicago (2005 - 2007)

Judicial Officer, Office of the Dean of Students, University of Illinois at Chicago Judicial Affairs (February 2005 - February 2008)

COLLEGE/DEPARTMENT Administrator, Pledge of Commitment, White Coat Ceremony, College of

Pharmacy, Western University of Health Sciences, (August 6 2016) Chair, Faculty Orientation and Development Committee, College of Pharmacy,

Western University of Health Sciences, (August 1 2016 - present); Member/Vice Chair/Chair Elect, Faculty Orientation and Development Committee, College of Pharmacy, Western University of Health Sciences, (August 1 2015 – July 31 2016)

Member, Postdoc Development Program Committee (ad hoc), Department of Pharmaceutical Sciences, College of Pharmacy, Western University of Health Sciences, January 2014 – June 30 2016

Chair, Assessment Committee, College of Pharmacy, Western University of Health Sciences, (November 2012 - July 2013); Vice-Chair, Assessment Committee, College of Pharmacy, Western University of Health Sciences, (August 2011 - November 2012); Chair, Assessment Committee, College of Pharmacy, Western University of Health Sciences, (August 2010 - July 2011); Vice-Chair, Assessment Committee, College of Pharmacy, Western University of Health Sciences, (August 2009 - August 2010); Member, Assessment Committee, College of Pharmacy, Western University of Health Sciences, (August 2008 - July 2013)

Parliamentarian, College of Pharmacy (August 2012 - July 2013) Chair, Policy Oversight Committee, College of Pharmacy, Western University of

Health Sciences, (August 2012 - July 2013) Vice-Chair, Department of Pharmaceutical Sciences Committee, College of

Pharmacy, Western University of Health Sciences, (July 1 2011 - June 30 2012) Chair, Pharmacy Faculty Assembly, College of Pharmacy, Western University of

Health Sciences, (August 2011 - July 2012); Chair-Elect, Pharmacy Faculty Assembly, College of Pharmacy, Western University of Health Sciences, (September 2010-July 2011)

Member, Dean’s Council, College of Pharmacy, Western University of Health Sciences (August 2011 - July 2012)

Member, ACPE Self Study Steering Committee, College of Pharmacy, Western University of Health Sciences, (May 2011 – October 2012)

Chair, Mission, Planning and Evaluation Section (Section I), ACPE Self Study Committee, College of Pharmacy, Western University of Health Sciences, (May 2011 - October 2012)

Judge, AE (Advanced Elective) Poster Day, College of Pharmacy, Western University of Health Sciences (May 2011 & 2012)

Member, Student Conduct Committee (Ad Hoc), College of Pharmacy, Western University of Health Sciences, (March 2011 - June 2011)

Chair, Annual Department Peer Assessment Committee, The Department of Pharmaceutical Sciences, College of Pharmacy, Western University of Health Sciences (2010 Performance Evaluation); Member, Annual Department Peer Assessment Committee, The Department of Pharmaceutical Sciences, College of Pharmacy, Western University of Health Sciences (2008 & 2009 Performance Evaluation)


Presenter, Preview Day of Western University, Master of Science in Pharmaceutical Sciences, program, Western University of Health Sciences (August 28 2010; August 27 2016)

Chair, Resource Allocation Committee (ad hoc), Department of Pharmaceutical Sciences, College of Pharmacy, Western University of Health Sciences, (July 2010 - April 2011)

Member, Pharmacy Practice and Administration Faculty Search Committee (Ad Hoc), The Department of Pharmacy Practice and Administration, College of Pharmacy, Western University of Health Sciences, (July 2010 - July 2011)

Member, Pharm Sci Faculty Search Committee (Ad Hoc), The Department of Pharmaceutical Sciences, College of Pharmacy, Western University of Health Sciences, (July 2010 - April 2011); Member, Pharm Sci Faculty Search Committee (Ad Hoc), The Department of Pharmaceutical Sciences, College of Pharmacy, Western University of Health Sciences, (August 2009 - January 2010).

Member, Pharmaceutical Sciences Chair Search Committee (Ad Hoc), The Department of Pharmaceutical Sciences, College of Pharmacy, Western University of Health Sciences, (March 2010 -June 2011)

Member, Self-Study Committee, Master of Science in Pharmaceutical Sciences (Contributed the “Physical Resources” Section, Department of Pharmaceutical Sciences; (2010)

White Coat “Coater”, White Coat Ceremony, College of Pharmacy, Western University of Health Sciences (August 8 2009, August 7 2010 & August 8 2015)

Elected Member, Policy Oversight Committee, College of Pharmacy, Western University of Health Sciences, (Academic years 2008 - 2009 & 2009 - 2010)

Co-Assessor, Peer Formative Assessment of Teaching, College of Pharmacy, Western University of Health Sciences, February, 2009.

Interviewer, Pharm.D. and IPBP Programs, Western University of Health Sciences College of Pharmacy, (February 2008 - Present)

Tour Guide, Research Laboratories, Department of Pharmaceutical Sciences Representative, Joint Research Retreat, Western University of Health Sciences And Charles Drew University of Medicine and Science, (October 29 2008).

Faculty-Student Representative, Department of Pharmacology, University of Illinois at Chicago (Academic Years 2003 - 2004 & 2004 - 2005)

PROFESSIONAL/SCIENTIFIC SOCIETIES AND ORGANIZATIONS Reviewer, Scientific Sessions 2016 abstracts, American Heart Association (April 5, 2016 -

present) Reviewer, 2016 AACP Annual Meeting Abstracts, American Association of Colleges of

Pharmacy (March 2016 - present) Reviewer, Medical Research Council, Research Councils UK, United Kingdom (November

2015) Reviewer, Hematology VA Merit Review Committee, Veterans Health Administration

(November 2015) Reviewer, AACP New Investigator Award, American Association of Colleges of Pharmacy

(October 2015 & October 2013) Co-Chair, Thrombosis Basic 1 Peer Review Committee, The American Heart

Association, (July 2015 - present); Member, Thrombosis Basic 1 Peer Review Committee, The American Heart Association, (December 2012 - present)

Member, Nominating Committee, AACP Biological Sciences Section (July 2014 - present) Past Chair, Biological Sciences Section, American Association of Colleges of

Pharmacy (AACP; July 24 2016 – present); Chair, Biological Sciences Section, American Association of Colleges of Pharmacy (AACP; July 15 2015 – July 24 2016); Chair-Elect, Biological Sciences Section, American Association of Colleges of Pharmacy (AACP; July 1 2014 - present); Chair-Elect Designate, Biological Sciences Section, American Association of Colleges of Pharmacy (AACP; December 2013-June 2014)

Secretary/Treasurer, Division of Cardiovascular Pharmacology, The American Society for Pharmacology and Experimental Therapeutics (July 1 2014 – June 30 2016); Secretary/Treasurer Elect, Division of Cardiovascular Pharmacology, The


American Society for Pharmacology and Experimental Therapeutics, (January 2013-June 30 2014).

Alternate Delegate, College of Pharmacy, Western University of Health Sciences, AACP House of Delegates, 2016 AACP Annual Meeting (2016)

External Reviewer/Member (ad hoc), Promotion & Tenure Committee, School of Pharmacy, Lebanese American University, (February 27, 2015 - present).

Member, Networking Task Force for the Council of Sections of AACP, Member (August 2014 - present)

Judge, ASPET Student/Postdoctoral Best Abstract Competition (April 2016; March 2015; April 2013; April 2012).

Member, Programming Committee, The American Society for Pharmacology and Experimental Therapeutics (July 1 2014 - present).

Chair, Programming Committee, Division of Cardiovascular Pharmacology, The American Society for Pharmacology and Experimental Therapeutics (July 1 2014 – June 30 2016).

Academic Editor, Medicine, Wolters Kluwer Health Medical Research (July 22 2014 - present)

Member (ad hoc), Hemostasis and Thrombosis (HT) Study Section, NIH Heart, Lung and Blood Institute, (December 2013 - February 2014)

Member, Nominating Committee, American Society for Pharmacology and Experimental Therapeutics (August 2013 - present)

Member, Innovative Research Grant (IRG) Vascular Regulation & Disease 2 Peer Review Committee, The American Heart Association, (July 2016 - present); Member, Innovative Research Grant (IRG) Vascular Regulation & Disease 2 Peer Review Committee, The American Heart Association, (July 2013 - November 2014); Member, Innovative Research Grant (IRG) Vascular Regulation & Disease 2 Peer Review Committee, The American Heart Association, (September 2012 - December 2012)

Member, Editorial Board, Frontiers Journal (June 2013 - present) Member, Student Undergraduate Research Fellowship Peer Review Committee,

The American Heart Association, (February 2012 - September 2012) Judge, Intel International Science and Engineering Fair (ISEF), Los Angeles, CA (May 10-

11, 2011) Editor-in-Chief, Pharma Scientist, March 2011-September 2012 Member, Virtual Pharmacology Focus Group, Lippincott, Williams & Wilkins, January 12

2011 Member, Continuing Professional Education (CPE) section, American Association

of Colleges of Pharmacy (AACP), (September 2010 - July 2013) Chair, Trainee Showcase Symposium Committee, Division of Cardiovascular

Pharmacology, The American Society for Pharmacology and Experimental Therapeutics, (November 2010 - June 2011).

Item Writer, Pharmacy Curriculum Outcomes Assessment (PCOA) Examination, AND Foreign Pharmacy Graduate Equivalency Examination (FPGEE), National Association of Boards of Pharmacy (Since October 2010)

Member, Executive Committee, Division of Cardiovascular Pharmacology, The American Society for Pharmacology and Experimental Therapeutics, (July 2010 – present).

Item Writer, North American Pharmacist Licensure Examination (NAPLEX), National Association of Boards of Pharmacy (Since March 25 2010)

Member, Competition Committee, Division of Cardiovascular Pharmacology, The American Society for Pharmacology and Experimental Therapeutics, July 2009 - present.

Judge, California State Science Fair, Los Angeles, CA (2009, 2010, 2012, 2015) Book Reviewer, Principles of Pharmacology, The Pathophysiologic Basis of Drug

Therapy, second edition, by David E. Golan, Lippincott Williams & Wilkins (2008) Co-Chair, Junior Scientists’ Symposium, Cardiovascular Pharmacology Division,

American Society for Pharmacology and Experimental Therapeutics, Experimental Biology Meeting, San Diego, CA (April 5 - 9, 2008)

Reviewer (October 2010 - present), - present (June 2011 - present); (March 2012 - present); PONE (July 2012 - present); (October 2012 - present); (2013 - present); 2013 - present); Blood (July 2014 - present); (February 2015 - present); Journal of Hematology & Oncology (April 2015 - present); Circulation Research journal (May 9 2015 - present); Cell


Biology International (June 22 2015 - present); Clinical Science (September 2015 - present); Nature Communications (September 2015 - present); Journal of Thrombosis and Haemostasis (October 2015 - present).

Group Guide, 2006 Students at Sessions, American Heart Association scientific Sessions 2006, group guide for high school students from across the metro Chicago (November 14, 2006)

Student Volunteer Group Leader, 2006 International Conference, Frontiers of Pharmacology and Toxicology, Chicago, Illinois (August 28 - 31, 2006)

Team Captain, Annual Fund-raising Heart Walk, American Heart Association (September 2005) Judge, Regional Science Fair, Martin Luther King High School, Chicago, Illinois (March 2004)

Judge, Jones College Preparatory High School Science Fair, Chicago, Illinois (December 2003 & 2004)


fadi khasawneh_cv - faculty profileshb2504.utep.edu/vitas/fkhasawneh.doc · web viewkhasawneh...

Documents